Prelude Therapeutics Incorporated
NASDAQ:PRLDBiotechnology
Healthcare
$3.32 -3.22%
-$0.14 today
- Market cap
- $192.16M
- Beta
- 1.01
- P/E (TTM)
- -4.5
- EPS (TTM)
- -$0.94
52W Low $0.75High $5.54
Volume 0.42M
Average 0.38M
Private 5-step workspace
Build a PRLD investment thesis
Turn Prelude Therapeutics Incorporated research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.